JANUMET - 0006-0081-14 - (sitagliptin and metformin hydrochloride)

Alphabetical Index


Drug Information of JANUMET

Product NDC: 0006-0081
Proprietary Name: JANUMET
Non Proprietary Name: sitagliptin and metformin hydrochloride
Active Ingredient(s): 1000; 100    mg/1; mg/1 & nbsp;   sitagliptin and metformin hydrochloride
Administration Route(s): ORAL
Dosage Form(s): TABLET, FILM COATED, EXTENDED RELEASE
Coding System: National Drug Codes(NDC)

Labeler Information of JANUMET

Product NDC: 0006-0081
Labeler Name: Merck Sharp & Dohme Corp.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA202270
Marketing Category: NDA
Start Marketing Date: 20120202

Package Information of JANUMET

Package NDC: 0006-0081-14
Package Description: 2 BOTTLE in 1 CARTON (0006-0081-14) > 7 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0006-0081-07)

NDC Information of JANUMET

NDC Code 0006-0081-14
Proprietary Name JANUMET
Package Description 2 BOTTLE in 1 CARTON (0006-0081-14) > 7 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0006-0081-07)
Product NDC 0006-0081
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name sitagliptin and metformin hydrochloride
Dosage Form Name TABLET, FILM COATED, EXTENDED RELEASE
Route Name ORAL
Start Marketing Date 20120202
Marketing Category Name NDA
Labeler Name Merck Sharp & Dohme Corp.
Substance Name METFORMIN HYDROCHLORIDE; SITAGLIPTIN PHOSPHATE
Strength Number 1000; 100
Strength Unit mg/1; mg/1
Pharmaceutical Classes Dipeptidyl Peptidase 4 Inhibitor [EPC],Dipeptidyl Peptidase 4 Inhibitors [MoA],Biguanide [EPC],Biguanides [Chemical/Ingredient]

Complete Information of JANUMET


General Information